Dr. Stacey Adam is the Scientific Program Manager for Cancer at the Foundation for the National Institutes of Health (FNIH). In her role, she leads the Cancer Research Partnership programs. She is a molecular pharmacologist/cancer biologist skilled in molecular biology techniques, animal modeling, clinical genomics, systems biology, project and team management, and strategy consulting. Prior to FNIH, Dr. Adam was a Manager at Deloitte Consulting within the Federal Life Sciences and Healthcare Strategy practice where she supported a number of federal and non-profit client projects. She was the project manager and scientific research advisor for an Institute-wide research strategic planning effort for an institute at the NIH and for a project to develop a novel technology platform to assist a major non-profit agency with combining clinical, genomic, and patient-generated data to accelerate research on chronic gastrointestinal diseases. She also worked for two years with a federally-associated non-profit granting agency as a scientific review officer. Before Deloitte, Dr. Adam conducted her postdoctoral fellowship at Stanford University School of Medicine, Department of Oncology where she was both an NIH and American Cancer Society supported fellow. While at Stanford, she focused on developing better animal models for studying lymphoma and osteosarcoma; performing large cancer genomics screens for genes related to self-renewal, differentiation, and tumor recurrence; merging high-throughput biological techniques with novel cancer animal models to define molecular disease signatures to allow for rapid diagnosis and prognosis of cancer; and working with companies to test novel compounds in pre-clinical trials.